These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6084863)

  • 1. Modulation of gene expression during terminal cell differentiation: murine erythroleukemia.
    Marks PA; Murate T; Kaneda T; Ravetch J; Rifkind RA
    Symp Fundam Cancer Res; 1984; 37():327-40. PubMed ID: 6084863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of gene expression during terminal cell differentiation.
    Marks PA; Sheffery M; Rifkind RA
    Prog Clin Biol Res; 1985; 191():185-203. PubMed ID: 3901038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
    Marks PA; Michaeli J; Jackson J; Richon VM; Rifkind RA
    Prog Clin Biol Res; 1989; 316B():171-81. PubMed ID: 2616574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells.
    Richon VM; Rifkind RA; Marks PA
    Cell Growth Differ; 1992 Jul; 3(7):413-20. PubMed ID: 1419904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process.
    Chen Z; Banks J; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):471-5. PubMed ID: 6952199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of globin gene expression during induced erythroid cell differentiation.
    Rifkind RA; Sheffery M; Profous-Juchelka HR; Reuben RC; Marks PA
    Prog Clin Biol Res; 1983; 134():183-92. PubMed ID: 6582518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression during terminal differentiation: dexamethasone suppression of inducer-mediated alpha 1- and beta maj-globin gene expression.
    Kaneda T; Murate T; Sheffery M; Brown K; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5020-4. PubMed ID: 3860841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
    Marks PA; Ramsay R; Sheffery M; Rifkind RA
    Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducer-mediated commitment of murine erythroleukemia cells to terminal cell division: the expression of commitment.
    Murate T; Kaneda T; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3394-8. PubMed ID: 6203120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced erythroleukemia differentiation: cellular and molecular aspects.
    Rifkind RA; Sheffery M; Marks PA
    Blood Cells; 1987; 13(1-2):277-84. PubMed ID: 3311222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in p34cdc2 kinase activity and cyclin A during induced differentiation of murine erythroleukemia cells.
    Kiyokawa H; Ngo L; Kurosaki T; Rifkind RA; Marks PA
    Cell Growth Differ; 1992 Jun; 3(6):377-83. PubMed ID: 1419901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the Friend system.
    Tsiftsoglou AS; Wong W
    Anticancer Res; 1985; 5(1):81-99. PubMed ID: 3888045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
    Marks PA; Rifkind RA
    Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA polymerase II inhibitor, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) causes erythroleukemic differentiation and transcriptional activation of erythroid genes.
    Hensold JO; Barth D; Stratton CA
    J Cell Physiol; 1996 Jul; 168(1):105-13. PubMed ID: 8647904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
    Chen ZX
    Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):261-4. PubMed ID: 1806345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell division.
    Ramsay RG; Ikeda K; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6849-53. PubMed ID: 3462732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of hemoglobin accumulation and commitment during murine erythroleukemia cell differentiation by treatment with imidazole.
    Gusella JF; Tsiftsoglou AS; Volloch V; Weil SC; Neumann J; Housman DE
    J Cell Physiol; 1982 Oct; 113(1):179-85. PubMed ID: 6957412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced differentiation of murine erythroleukemia cells: cellular and molecular mechanisms.
    Rifkind RA; Sheffery M; Marks PA
    Adv Cancer Res; 1984; 42():149-66. PubMed ID: 6395654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells.
    Corin RE; Haspel HC; Peretz AM; Sonenberg M; Rifkind RA
    Cancer Res; 1986 Mar; 46(3):1136-41. PubMed ID: 3455880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Factors controlling the differentiation and cancerization of murine erythroleukemia cells].
    Obinata M
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):1989-95. PubMed ID: 3475040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.